Namanidhi Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.40 M
- Satisfied Charges ₹ 3.00 M
- Revenue Growth 4.44%
- Profit Growth -57.94%
- Ebitda -46.82%
- Net Worth -27.88%
- Total Assets 44.50%
About Namanidhi Pharmaceutical
Namanidhi Pharmaceutical Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 July 2017 (Seven years and six months 28 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.40 M. The company has closed loans amounting to ₹3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ramesh Kothari and Mamta Kothari serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999GJ2017PTC098329
-
Company No.
098329
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Jul 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Namanidhi Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Kothari
|
Director | 18-Jul-2017 | Current |
|
Mamta Kothari
|
Director | 16-Dec-2019 | Current |
Financial Performance of Namanidhi Pharmaceutical.
Namanidhi Pharmaceutical Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.44% increase. The company also saw a substantial fall in profitability, with a 57.94% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Namanidhi Pharmaceutical?
In 2023, Namanidhi Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Rajsons Pharma Private LimitedRamesh Kothari and Mamta Kothari are mutual person
Charges (Loans)
₹2.40 M
₹3.00 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.24 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Nov 2021 | Axis Bank Limited | ₹2.40 M | Open |
| 26 Mar 2018 | Hdfc Bank Limited | ₹3.00 M | Satisfied |
How Many Employees Work at Namanidhi Pharmaceutical?
Unlock and access historical data on people associated with Namanidhi Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Namanidhi Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Namanidhi Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
